相关实验视频
Updated: Jan 8, 2026

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
9.2K
毒药免疫疗法在预防严重蜜蜂和黄蜂刺反应方面的成本效益
Gunter Sturm1,2, Maria Beatrice Bilò3,4, Carmen Vidal5
1Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
Allergy
|December 18, 2025
概括
毒药免疫疗法 (VIT) 是对严重的蜂和黄蜂刺系统性刺反应的成本有效的预防性治疗方法,比像上腺素自动注射器 (AAI) 这样的紧急治疗更有价值. 这种方法可以改善过敏患者的生活质量.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 卫生经济学 卫生经济学
- 药物经济学 药物经济学
背景情况:
- 系统性刺伤反应 (SSR) 对于黄斑虫的刺伤构成严重的健康风险,包括过敏反应和潜在的死亡.
- 害怕刺伤会影响日常生活;毒药免疫疗法 (VIT) 提供预防性治疗.
- 上腺素自动注射器 (AAI) 是紧急治疗方法,而VIT提供了一个主动的方法.
研究的目的:
- 从丹麦付款人的角度来评估VIT (Alutard® SQ) 与AAI用于管理蜜蜂和/或黄蜂毒素过敏的成本效益.
- 评估黑虫毒库免疫疗法 (HVDI) 的长期经济效益.
主要方法:
- 通过结构化的文献审查和专家共识,开发了一个决策树框架.
- 增量成本效益比率 (ICER) 计算在10年的时间内.
- 为了评估不确定性,进行了单变量决定性灵敏度分析 (DSA).
主要成果:
- HVDI的增量成本为7428欧元,获得了0.48增量质量调整寿命年 (QALYs).
- 与AAI相比,HVDI的估计ICER为每QALY在10年内获得的15,550欧元.
结论:
- 毒药免疫疗法 (VIT) 是一种具有成本效益的策略,用于预防对黑虫的严重反应.
- 与仅依靠AAI来管理毒素过敏相比,HVDI具有有利的成本效益.
相关概念视频
Allergic Reactions
31.9K
Overview
31.9K
Cross-reactivity
32.8K
Overview
32.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Vaccinations
51.1K
Overview
51.1K

